Dan Pikus

Dan Pikus serves as a key procurement professional within the W4PZ USA Medical Research Acquisition Act, operating under the Department of the Army’s Medical Research and Development Command. He is responsible for managing complex research and development contracts that translate cutting-edge biomedical innovations into field-deployable capabilities for warfighter health and readiness. His portfolio focuses on professional, scientific, and technical services that support advanced diagnostics, therapeutic development, and analytical technologies essential to military medical readiness. Pikus ensures acquisitions align with DoD strategic priorities by evaluating technical merit, scalability, and transition readiness of proposed solutions. Pikus collaborates with a diverse ecosystem of contractors, including academic research institutions, biotechnology startups, and specialized defense contractors with expertise in life sciences and clinical diagnostics. He fosters long-term partnerships with vendors capable of delivering high-risk, high-reward R&D outcomes, often requiring agile contract structures such as Other Transaction Authorities (OTAs) and Broad Agency Announcements (BAAs). His procurement approach emphasizes technical collaboration over transactional vendor relationships, encouraging innovation through early-stage engagement and iterative prototyping. Pikus maintains a uniform preference for non-set-aside acquisitions, with 100% of procurements conducted under unrestricted competition. This reflects the mission-critical nature of the research being funded, where technical capability and scientific rigor take precedence over socioeconomic preferences. While small business participation is not formally prioritized through set-asides, he actively encourages participation from qualified small firms through open solicitations and mentor-protégé initiatives. His primary procurement focus is on NAICS 541990 — All Other Professional, Scientific, and Technical Services — encompassing advanced biomedical research, bioinformatics, point-of-care diagnostics, and translational medicine. He routinely procures services in molecular biology, neurotechnology, trauma response systems, and countermeasure development, requiring deep domain expertise in life sciences and defense medical innovation.